Registration - In-house Corporation

Kenvue Canada Inc. / Katie Decker, Managing Director, Canada

Registration Information

In-house Corporation name: Kenvue Canada Inc.
Previous in-house corporation names
Responsible Officer Name: Katie Decker, Managing Director, Canada
Responsible Officer Change History
Initial registration start date: 2009-03-31
Registration status: Active
Registration Number: 955130-220221

Associated Communications

Total Number of Communication Reports: 242

Monthly communication reports in the last 6 months: 2

Version 40 of 50 (2022-01-31 to 2022-02-01)

Registration versions:

Version 40 of 50 (2022-01-31 to 2022-02-01)

Lobbying Information

Subject Matters

Budget
Consumer Issues
Environment
Health
Industry
Intellectual Property
International Trade
Taxation and Finance

Subject matters added through a monthly communication report

Economic Development

Subject Matter Details

Legislative Proposal, Bill or Resolution

Changes to NAFTA to address United States-Mexico-Canada Agreement (USMCA) relevant for life sciences sector
Communication regarding the review by the Health Committee on regulation of e-cigarettes.
Zero plastic waste by 2030 – Regarding potential legislative proposal regulating harmful single-use plastic items and implementing plastic waste management programs.

Policies or Program

COVID-19: Regarding the development of policies and programs to address the COVID-19 pandemic and support the re-opening of the Canadian economy, including as it relates to tackling health equity across marginalized communities in Canada and surgical backlogs.
Canada’s engagement and leadership on programs and policies relating to mental health both domestic and international
Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Agreement (NAFTA) and any other agreements as it relates to intellectual property considerations and other aspects which affect the local business environment for J&J companies
Canada’s partnerships on global health and global community impact with Johnson & Johnson relating to maternal and child health, First Nations, mental health and other areas
Chemical Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in therapeutic products
Communiation to officials regarding the Regulatory Cooperation council.
Engagement on government’s Innovation Agenda as it relates to Health and Bio Sciences sector
Evolution of role and mandate of drug pricing regime in Canada
Food and Drug Act: Delays in product approvals and changes to existing products
Local manufacturing of healthcare products – Regarding the development of policies and programs (including funding programs) to support the expansion of existing manufacturing facilities or the establishment of additional manufacturing capacity in Canada.
Self-care – Regarding the development of policies and programs to support self-care, including tax incentives for self-care products that have an impact on health (for e.g. sunscreen, smoking cessation).
Smoking cessation – Regarding the development of federally funded programs or other policies to facilitate smoking cessation (for e.g. tobacco tax).
Treasury Board initiative to address international regulatory cooperation as well as their work on the Canada US, and Canada EU Regulatory Cooperation Councils

Policies or Program, Regulation

Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drug Act and Regulations, specifically with respect to approval, regulation and life cycle management of therapeutic products

Regulation

Communication to officials on labelling and product monographs.
Communication to officials regarding Look Alike Sound Alike Guidance communication.
Food and Drug Regulation: Nonprescription drugs labelling standards - Drug Products: Draft Guidance Document: Nonprescription Oral Pediatric Cough and Cold Labelling Standard,participated in Health Canada's consultation process
Modernizations of the Food and Drugs Act, with respect to inspection, reporting and confidential business information
any regulatory changes that may emerge relating to the policy areas identified above including Health Canada Modernization efforts, Patented Medicine Prices Review Board (PMPRB), Treasury Board Initiative on international regulatory cooperation

Communication Techniques

Written communication
Oral communication

Government Institutions

Canada Economic Development for Quebec Regions
Canada Revenue Agency (CRA)
Canadian Heritage (PCH)
Canadian Radio-television and Telecommunications Commission (CRTC)
Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)
Employment and Social Development Canada (ESDC)
Environment and Climate Change Canada (ECCC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Justice Canada (JC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada
Transportation Safety Board of Canada (TSB)
Transport Canada (TC)
Treasury Board Of Canada Secretariat (TBS)

In-house Corporation Details

Description of activities

We produce and market over the counter medications

Responsible officer name and position during the period of this registration

Cory Price, Managing Director

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
88 McNabb Street
Markham, ON L3R 5L2
Canada

Telephone number: 905-968-2225

Parent Company Information

Johnson & Johnson
- 410 George Street
  New Brunswick, NJ 08901
  United States of America

Subsidiary Beneficiary Information

Johnson & Johnson Inc. (Consumer)
- 88 McNabb Street
  Markham, ON L3R 5L2
  Canada
Johnson & Johnson Medical Products
- 200 Whitehall Drive
  Markham, ON L3R 0T5
  Canada
Johnson & Johnson Vision Care
- 200 Whitehall Drive
  Markham, ON L3R 0T5
  Canada
McNeil Consumer Healthcare
- 88 McNabb Street
  Markham, ON L3R 5L2
  Canada

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Andrea Freund, Vice President, Legal | No public offices held
Katherine Lal, Leader, Communications & Government Affairs | No public offices held
Hillary Orr, Director, Regulatory Affairs | No public offices held
Anuj Pasrija, Vice President - Strategic Customer Group & Solutions | No public offices held
Cory Price, Managing Director | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Lesia Babiak, Executive Director, Worldwide Government Affairs & Policy (Canada) | No public offices held
Roberta Kramchynsky, Senior Manager, Government Affairs & Policy | Public offices held
Geneviève Lavertu, Director, Government Affairs and Policy – Medical Technology | Public offices held
Jim Pimblett, Director, Government Affairs and Policy | Public offices held

Kenvue Canada Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Kenvue Canada Inc./	2024-04-01	current
Johnson & Johnson Inc.	2009-03-31	2024-04-01

Kenvue Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Katie Decker	2023-06-01	Current
Cory Price	2019-01-01	2023-06-01
Paul Copeland	2016-05-01	2019-01-01
Louisa Greco	2013-06-06	2016-05-01
Patrick Smallcombe	2011-05-11	2013-06-06
William Murphy	2009-03-31	2011-05-11

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Special Assistant House of Commons, Office of Ted Menzies, MP	September 2006 to November 2007	Not a designated office
Member's Assistant House of Commons, Office of Hon. Carol Skelton, PC, MP	February 2006 to July 2006	Not a designated office
Administrative Assistant House of Commons, Office of the Leader of the Opposition	September 2004 to January 2006	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Special Assistant House of Commons, Office of Ted Menzies, MP	September 2006 to November 2007	Not a designated office
Member's Assistant House of Commons, Office of Hon. Carol Skelton, PC, MP	February 2006 to July 2006	Not a designated office
Administrative Assistant House of Commons, Office of the Leader of the Opposition	September 2004 to January 2006	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Director of Parliamentary Affairs/Executive Assistant to the Leader of the Opposition House of Commons, Office of the Leader of the Opposition	July 2009 to May 2010	Not a designated office
Executive Assistant to the Prime Minister Privy Council Office, Office of the Prime Minister	December 2003 to February 2006	Not a designated office
Legislative Assistant to the Prime Minister of Finance Finance Canada, Office of the Minister of Finance	January 2000 to June 2002	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legal Counsel President of the Queen's Privy Council for Canada, Chief Electoral Officer of Canada	August 1992 to August 1994	Not a designated office

Date Modified:: 2024-11-13

Search and menus

Language selection

Registration - In-house Corporation

Kenvue Canada Inc. / Katie Decker, Managing Director, Canada

Registration Information

Associated Communications

Version 40 of 50 (2022-01-31 to 2022-02-01)

Version 40 of 50 (2022-01-31 to 2022-02-01)

Subject Matters

Subject matters added through a monthly communication report

Subject Matter Details

Legislative Proposal, Bill or Resolution

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties